Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study

被引：0
|
作者：
Gilbert, D.
Kim, D.
Miller, M.
Horine, S.
Saljooqi, K.
Karkanias, G.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
149
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study
    Gilbert, D.
    Kim, D.
    Miller, M.
    Horine, S.
    Saljooqi, K.
    Karkanias, G.
    Wanaski, S.
    Cunniff, T.
    MOVEMENT DISORDERS, 2023, 38 : S421 - S421
  • [2] Safety and efficacy of long-term treatment with transdermal rotigotine in patients with idiopathic restless legs syndrome: A 12-month open-label extension study
    Benes, H.
    Garcia-Borreguero, H.
    Oertel, W.
    Fichtner, A.
    Schollmayer, E.
    Trenkwalder, C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S515 - S515
  • [3] Long-term efficacy and safety of pegcetacoplan over 36 months including 12-month results of the GALE open-label extension study
    Abbey, Ashkan Michael
    Wykoff, Charles C.
    Heier, Jeffrey S.
    Li, Chao
    Yemanyi, Felix
    Dieckmann, Gabriela
    Pereria, Daniel
    Tsuboi, Min
    Baumal, Caroline
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [4] Ecopipam Does Not Adversely Affect Metabolic Parameters in Pediatric Patients With Tourette Syndrome (TS): Results From a Phase 2b Randomized, Placebo-Controlled Trial (RCT) With a 12-Month Open-Label Extension (OLE)
    Gilbert, D. L.
    Atkinson, S. D.
    Karkanias, G. B.
    Munschauer, F.
    Wanaski, S.
    Cunniff, T.
    ANNALS OF NEUROLOGY, 2025, 96 : S62 - S62
  • [5] Ecopipam does not adversely affect Metabolic Parameters in Pediatric Subjects with Tourette Syndrome: Results from a Phase 2b with 12-month Open Label Extension Study
    Gilbert, D.
    Atkinson, S.
    Karkanias, G.
    Munschauer, F.
    Wanaski, S.
    Cunniff, T.
    MOVEMENT DISORDERS, 2024, 39 : S292 - S292
  • [6] Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
    Adams, David
    Polydefkis, Michael
    Gonzalez-Duarte, Alejandra
    Wixner, Jonas
    Kristen, Arnt, V
    Schmidt, Hartmut H.
    Berk, John L.
    Losada Lopez, Ines Asuncion
    Dispenzieri, Angela
    Quan, Dianna
    Conceicao, Isabel M.
    Slama, Michel S.
    Gillmore, Julian D.
    Kyriakides, Theodoros
    Ajroud-Driss, Senda
    Waddington-Cruz, Marcia
    Mezei, Michelle M.
    Plante-Bordeneuve, Violaine
    Attarian, Shahram
    Mauricio, Elizabeth
    Brannagan, Thomas H., III
    Ueda, Mitsuharu
    Aldinc, Emre
    Wang, Jing Jing
    White, Matthew T.
    Vest, John
    Berber, Erhan
    Sweetser, Marianne T.
    Coelho, Teresa
    LANCET NEUROLOGY, 2021, 20 (01): : 49 - 59
  • [7] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [8] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [9] Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
    Filts, Yuriy
    Litman, Robert E.
    Martinez, Javier
    Anta, Lourdes
    Naber, Dieter
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2022, 239 : 83 - 91
  • [10] LONG-TERM TREATMENT WITH TRANSDERMAL ROTIGOTINE IN PATIENTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM A 12-MONTH OPEN-LABEL EXTENSION TRIAL
    Allen, R. P.
    Winkelman, J.
    Ondo, W.
    Fichtner, A.
    Schollmayer, E.
    SLEEP, 2010, 33 : A251 - A251
12345